OrsoBio Announces Acquisition of LXR Inverse Agonist Program

OrsoBio Announces Acquisition of LXR Inverse Agonist Program for Treatment of Severe Dyslipidemias from Phenex Pharmaceuticals

OrsoBio Announces Acquisition of LXR Inverse Agonist Program for Treatment of Severe Dyslipidemias from Phenex Pharmaceuticals
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Washington , United States , Claus Kremoser , Mani Subramanian , Gwen Gordon , Rob Myers , Srinivas Akkaraju , Zealand Clinicaltrials , Phenex Pharmaceuticals , Orsobio Inc , Liver Meeting , Liverx Receptor , Chief Medical Officer , Chief Executive Officer , New Zealand , Therapeutic Area Head , Liver Diseases , Gilead Sciences ,